Ncardia

Leiden, The Netherlands

Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.

Nov 2021

Venture - Series Unknown

Top Investors

InnovationQuarterVesalius Biocapital PartnersEISMEAS.R.I.W.Sambrinvest

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are Ncardia's investors?

Ncardia's investors include InnovationQuarter, Vesalius Biocapital Partners, EISMEA, S.R.I.W., Sambrinvest.

Where is Ncardia headquartered?

Ncardia is headquartered in Leiden, The Netherlands.

What does Ncardia do?

Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.

What stage is Ncardia at?

Ncardia is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 16, 2021.

MLA

"Ncardia — Funding & Investors." VCBacked, November 16, 2021, https://www.vcbacked.co/company/ncardia. Accessed July 1, 2026.

APA

VCBacked. (2021). Ncardia — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/ncardia

Wikipedia (cite web)

{{cite web |title=Ncardia — Funding & Investors |url=https://www.vcbacked.co/company/ncardia |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 16, 2021.